Paper39282196
The Impact of Fosfomycin on Gram Negative Infections: A Comprehensive Review.
Dubey S and 2 others. Indian J Microbiol, 2024. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. The Impact of Fosfomycin on Gram Negative Infections: A Comprehensive Review. Papers, record 39282196. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39282196
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References120
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14677948 | Mechanistic diversity of fosfomycin resistance in pathogenic microorganisms. | J Am Chem Soc | 2003 | https://conductscience.org/library/papers/14677948 | PubMed |
| 2 | 24379684 | Update on management options in the treatment of nosocomial and ventilator assisted pneumonia: review of actual guidelines and economic aspects of therapy. | Infect Drug Resist | 2013 | https://conductscience.org/library/papers/24379684 | PubMed |
| 3 | 23295934 | Activities of fosfomycin, tigecycline, colistin, and gentamicin against extended-spectrum-β-lactamase-producing Escherichia coli in a foreign-body infection model. | Antimicrob Agents Chemother | 2013 | https://conductscience.org/library/papers/23295934 | PubMed |
| 4 | 24315790 | In vitro and intracellular activities of fosfomycin against clinical strains of Listeria monocytogenes. | Int J Antimicrob Agents | 2014 | https://conductscience.org/library/papers/24315790 | PubMed |
| 5 | 4605290 | The mechanism of action of fosfomycin (phosphonomycin). | Ann N Y Acad Sci | 1974 | https://conductscience.org/library/papers/4605290 | PubMed |
| 6 | 2037534 | Effect of non-beta-lactam antibiotics on penicillin-binding protein synthesis of Enterococcus hirae ATCC 9790. | J Antimicrob Chemother | 1991 | https://conductscience.org/library/papers/2037534 | PubMed |
| 7 | 23546462 | [Increasing prevalence of fosfomycin resistance in extended-spectrum-beta-lactamase-producing Escherichia coli urinary isolates (2005-2009-2011)]. | Rev Esp Quimioter | 2013 | https://conductscience.org/library/papers/23546462 | PubMed |
| 8 | 19915879 | Fosfomycin: an old, new friend? | Eur J Clin Microbiol Infect Dis | 2010 | https://conductscience.org/library/papers/19915879 | PubMed |
| 9 | 8682732 | Fosfomycin monophosphate and fosfomycin diphosphate, two inactivated fosfomycin derivatives formed by gene products of fomA and fomB from a fosfomycin producing organism Streptomyces wedmorensis. | J Antibiot (Tokyo) | 1996 | https://conductscience.org/library/papers/8682732 | PubMed |
| 10 | 27956267 | Intravenous fosfomycin-back to the future. Systematic review and meta-analysis of the clinical literature. | Clin Microbiol Infect | 2017 | https://conductscience.org/library/papers/27956267 | PubMed |
| 11 | 25048851 | Efficacy and safety of fosfomycin plus imipenem as rescue therapy for complicated bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: a multicenter clinical trial. | Clin Infect Dis | 2014 | https://conductscience.org/library/papers/25048851 | PubMed |
| 12 | 27261267 | Glutathione-S-transferase FosA6 of Klebsiella pneumoniae origin conferring fosfomycin resistance in ESBL-producing Escherichia coli. | J Antimicrob Chemother | 2016 | https://conductscience.org/library/papers/27261267 | PubMed |
| 13 | 1963292 | Nucleotide sequence and intracellular location of the product of the fosfomycin resistance gene from transposon Tn2921. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/1963292 | PubMed |
| 14 | 28694609 | Role of Biofilm in Cerebrospinal Fluid Shunt Infections: A Study at Tertiary Neurocare Center from South India. | J Neurosci Rural Pract | 2017 | https://conductscience.org/library/papers/28694609 | PubMed |
| 15 | 9023661 | In-vitro activity of antimicrobial agent combinations against multiresistant Acinetobacter baumannii. | J Antimicrob Chemother | 1996 | https://conductscience.org/library/papers/9023661 | PubMed |
| 16 | 27584587 | The management of multidrug-resistant Enterobacteriaceae. | Curr Opin Infect Dis | 2016 | https://conductscience.org/library/papers/27584587 | PubMed |
| 17 | 28442293 | Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study. | Lancet Infect Dis | 2017 | https://conductscience.org/library/papers/28442293 | PubMed |
| 18 | 6348661 | [Diffusion of fosfomycin into bone tissue in man]. | Pathol Biol (Paris) | 1983 | https://conductscience.org/library/papers/6348661 | PubMed |
| 19 | 24107389 | Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin. | J Antimicrob Chemother | 2014 | https://conductscience.org/library/papers/24107389 | PubMed |
| 20 | 27401568 | Detection of mcr-1 among Escherichia coli Clinical Isolates Collected Worldwide as Part of the SENTRY Antimicrobial Surveillance Program in 2014 and 2015. | Antimicrob Agents Chemother | 2016 | https://conductscience.org/library/papers/27401568 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42847693 | Biapenem-fosfomycin shows enhanced in vitro activity compared with meropenem-fosfomycin against NDM-producing Enterobacterales. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/42847693 | PubMed |
| 42505654 | The Pharmacology of Bacterial Persistence: From Antibiotic Tolerance to Antimicrobial Resistance. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42505654 | PubMed |
| 42273017 | Emergence of Fosfomycin Resistance Among ESBL-Producing Escherichia coli in Abadan, Southwestern Iran. | Health Sci Rep | 2026 | https://conductscience.org/library/papers/42273017 | PubMed |
| 41627487 | Therapeutic milestones against multidrug resistant Acinetobacter baumannii: from legacy antibiotics to Zosurabalpin. | Arch Microbiol | 2026 | https://conductscience.org/library/papers/41627487 | PubMed |
| 40410452 | Fosfomycin for the treatment of patients with bacterial prostatitis: a systematic review. | Eur J Clin Microbiol Infect Dis | 2025 | https://conductscience.org/library/papers/40410452 | PubMed |
| 39948320 | Mechanisms, therapeutic strategies, and emerging therapeutic alternatives for carbapenem resistance in Gram-negative bacteria. | Arch Microbiol | 2025 | https://conductscience.org/library/papers/39948320 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39282196
GET https://conductscience.org/api/papers/v1/39282196/references?page=2